The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced. Dubbed IsoPSA, the in vitro diagnostic kit is ...
This, in turn, altered the configuration of the orbitals to achieve the half-Möbius configuration that the researchers were ...